SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-093086
Filing Date
2021-07-16
Accepted
2021-07-16 16:24:02
Documents
12
Period of Report
2021-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2122445d1_8k.htm   iXBRL 8-K 25835
  Complete submission text file 0001104659-21-093086.txt   197930

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elox-20210714.xsd EX-101.SCH 3197
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20210714_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20210714_pre.xml EX-101.PRE 22718
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2122445d1_8k_htm.xml XML 3504
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 211095714
SIC: 8731 Services-Commercial Physical & Biological Research